ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

KBLB Kraig Biocraft Laboratories Inc (QB)

0.09
-0.00075 (-0.83%)
02 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Kraig Biocraft Laboratories Inc (QB) USOTC:KBLB OTCMarkets Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.00075 -0.83% 0.09 0.0867 0.0939 0.0938 0.0864 0.0909 255,625 21:08:13

Kraig Biocraft Laboratories Announces U.S. Patent and Trademark Office Has Registered the Company's Monster Silk(R) Trademark...

15/07/2014 11:05am

GlobeNewswire Inc.


Kraig Biocraft Laborator... (QB) (USOTC:KBLB)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Kraig Biocraft Laborator... (QB) Charts.

Kraig Biocraft Laboratories, Inc. (OTCQB:KBLB) ("Company"), the leading developer of advanced spider silk based fibers, announces today that "Monster Silk®" is now a registered trademark with the U.S. Patent and Trademark Office. Monster Silk®, a genetically engineered spider silk fiber, is in the early stages of commercialization.

In addition to Monster Silk®, the U.S. Patent and Trademark Office has registered the Company's Spiderpillar® and Spilk® trademarks.

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies. The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company's future and expectations other than historical facts are "forward-looking statements." These statements are made on the basis of management's current views and assumptions. As a result, there can be no assurance that management's expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as "believes," "plans," "expects," "anticipates," "foresees," "estimated," "hopes," "if," "develops," "researching," "research," "pilot," "potential," "could" or other words or phrases of similar import. Forward looking statements include descriptions of the Company's business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements.

This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

CONTACT: Ben Hansel, Hansel Capital, LLC.
         (720) 288-8495
         ir@KraigLabs.com

1 Year Kraig Biocraft Laborator... (QB) Chart

1 Year Kraig Biocraft Laborator... (QB) Chart

1 Month Kraig Biocraft Laborator... (QB) Chart

1 Month Kraig Biocraft Laborator... (QB) Chart

Your Recent History

Delayed Upgrade Clock